StockNews.com initiated coverage on shares of Ultralife (NASDAQ:ULBI – Free Report) in a research note issued to investors on Sunday. The firm issued a buy rating on the technology company’s stock. Separately, TheStreet raised shares of Ultralife from a d+ rating to a c- rating in a research note on Wednesday, July 12th. Read Our […]
Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.
Ultralife Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 42.69 million compared to USD.
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.